Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,926 | -37,866 | -27,340 | -13,260 | -42,200 |
| Depreciation Amortization | 3,257 | 55 | 36 | 18 | 1,948 |
| Income taxes - deferred | -409 | N/A | N/A | N/A | N/A |
| Other Working Capital | 2,971 | 4,915 | 5,821 | 3,048 | 3,153 |
| Other Operating Activity | 2,218 | 1,010 | 831 | 1,979 | 2,138 |
| Operating Cash Flow | $-40,889 | $-31,887 | $-20,651 | $-8,215 | $-34,961 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -14 | -17 | N/A | -14 |
| Investing Cash Flow | $-14 | $-14 | $-17 | $N/A | $-14 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,495 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -5,138 |
| Financing Cash Flow | $4,495 | $N/A | $N/A | $N/A | $-5,138 |
| Exchange Rate Effect | 5 | -4 | 0 | 19 | -47 |
| Beginning Cash Position | 51,189 | 51,189 | 51,189 | 51,189 | 91,349 |
| End Cash Position | 14,786 | 19,284 | 30,522 | 42,993 | 51,189 |
| Net Cash Flow | $-36,403 | $-31,905 | $-20,667 | $-8,196 | $-40,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,889 | -31,887 | -20,651 | -8,215 | -34,961 |
| Capital Expenditure | -14 | -14 | -17 | N/A | -16 |
| Free Cash Flow | -40,903 | -31,901 | -20,667 | -8,215 | -34,978 |